Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting
P. Bruland, M. McGilchrist, E. Zapletal, D. Acosta, J. Proeve, S. Askin, T. Ganslandt, J. Doods, M. Dugas, BMC Medical Research Methodology 16 (2016).
Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz (wiss.)
| Veröffentlicht
| Englisch
Autor*in
Bruland, PhilippELSA 
;
McGilchrist, Mark;
Zapletal, Eric;
Acosta, Dionisio;
Proeve, Johann;
Askin, Scott;
Ganslandt, Thomas;
Doods, Justin;
Dugas, Martin
;
McGilchrist, Mark;
Zapletal, Eric;
Acosta, Dionisio;
Proeve, Johann;
Askin, Scott;
Ganslandt, Thomas;
Doods, Justin;
Dugas, MartinEinrichtung
Abstract
Background: Data capture is one of the most expensive phases during the conduct of a clinical trial and the increasing use of electronic health records (EHR) offers significant savings to clinical research. To facilitate these secondary uses of routinely collected patient data, it is beneficial to know what data elements are captured in clinical trials. Therefore our aim here is to determine the most commonly used data elements in clinical trials and their availability in hospital EHR systems.
Methods: Case report forms for 23 clinical trials in differing disease areas were analyzed. Through an iterative and consensus-based process of medical informatics professionals from academia and trial experts from the European pharmaceutical industry, data elements were compiled for all disease areas and with special focus on the reporting of adverse events. Afterwards, data elements were identified and statistics acquired from hospital sites providing data to the EHR4CR project.
Results: The analysis identified 133 unique data elements. Fifty elements were congruent with a published data inventory for patient recruitment and 83 new elements were identified for clinical trial execution, including adverse event reporting. Demographic and laboratory elements lead the list of available elements in hospitals EHR systems. For the reporting of serious adverse events only very few elements could be identified in the patient records.
Conclusions: Common data elements in clinical trials have been identified and their availability in hospital systems elucidated. Several elements, often those related to reimbursement, are frequently available whereas more specialized elements are ranked at the bottom of the data inventory list. Hospitals that want to obtain the benefits of reusing data for research from their EHR are now able to prioritize their efforts based on this common data element list.
Stichworte
Erscheinungsjahr
Zeitschriftentitel
BMC Medical Research Methodology
Band
16
Zeitschriftennummer
1
Artikelnummer
159
ISSN
ELSA-ID
Zitieren
Bruland P, McGilchrist M, Zapletal E, et al. Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting. BMC Medical Research Methodology. 2016;16(1). doi:10.1186/s12874-016-0259-3
Bruland, P., McGilchrist, M., Zapletal, E., Acosta, D., Proeve, J., Askin, S., Ganslandt, T., Doods, J., & Dugas, M. (2016). Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting. BMC Medical Research Methodology, 16(1), Article 159. https://doi.org/10.1186/s12874-016-0259-3
Bruland P et al. (2016) Common Data Elements for Secondary Use of Electronic Health Record Data for Clinical Trial Execution and Serious Adverse Event Reporting. BMC Medical Research Methodology 16.
Bruland, Philipp, Mark McGilchrist, Eric Zapletal, Dionisio Acosta, Johann Proeve, Scott Askin, Thomas Ganslandt, Justin Doods, and Martin Dugas. “Common Data Elements for Secondary Use of Electronic Health Record Data for Clinical Trial Execution and Serious Adverse Event Reporting.” BMC Medical Research Methodology 16, no. 1 (2016). https://doi.org/10.1186/s12874-016-0259-3.
Bruland, Philipp, Mark McGilchrist, Eric Zapletal, Dionisio Acosta, Johann Proeve, Scott Askin, Thomas Ganslandt, Justin Doods und Martin Dugas. 2016. Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting. BMC Medical Research Methodology 16, Nr. 1. doi:10.1186/s12874-016-0259-3, .
Bruland, Philipp ; McGilchrist, Mark ; Zapletal, Eric ; Acosta, Dionisio ; Proeve, Johann ; Askin, Scott ; Ganslandt, Thomas ; Doods, Justin ; u. a.: Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting. In: BMC Medical Research Methodology Bd. 16. London, Springer Science and Business Media LLC (2016), Nr. 1
P. Bruland, M. McGilchrist, E. Zapletal, D. Acosta, J. Proeve, S. Askin, T. Ganslandt, J. Doods, M. Dugas, Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting, BMC Medical Research Methodology. 16 (2016).
P. Bruland et al., “Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting,” BMC Medical Research Methodology, vol. 16, no. 1, Art. no. 159, 2016, doi: 10.1186/s12874-016-0259-3.
Bruland, Philipp, et al. “Common Data Elements for Secondary Use of Electronic Health Record Data for Clinical Trial Execution and Serious Adverse Event Reporting.” BMC Medical Research Methodology, vol. 16, no. 1, 159, 2016, https://doi.org/10.1186/s12874-016-0259-3.
Bruland, Philipp u. a.: Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting, in: BMC Medical Research Methodology 16 (2016), H. 1.
Bruland P, McGilchrist M, Zapletal E, Acosta D, Proeve J, Askin S, et al. Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting. BMC Medical Research Methodology. 2016;16(1).
Google Scholar